The Carthera team are gearing up for #SNO2024, which begins tomorrow! During the event, Carthera will be hosting a meeting with investigators of our SONOBIRD pivotal trial, which is comparing the use of our SonoCloud-9 device combined with carboplatin vs standard of care therapies in patients with first recurrence of #glioblastoma. 🤝 Meet our senior leaders and clinical team members Frédéric Sottilini (CEO), Michael Canney, Ph.D. (CSO) Carole Desseaux (CCO), Amanda Hoffmann(Clinical Trial Manager), Charlotte SCHMITT(Director of EU Clinical Operations) and Annie C. (Director, Clinical Operations). You can learn about our SONOBIRD trial on our new dedicated website 👇 www.sonobird.eu Find out more about SNO here👇 https://lnkd.in/ejbVQkgu #neurology #oncology #clinicaltrial
